ACLX
Arcellx Inc
NASDAQ: ACLX · HEALTHCARE · BIOTECHNOLOGY
$115.07
+0.00% today
Updated 2026-04-28
Market cap
$6.73B
P/E ratio
—
P/S ratio
302.04x
EPS (TTM)
$-4.07
Dividend yield
—
52W range
$48 – $115
Volume
2.8M
Arcellx Inc (ACLX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-9.8%
Last 4 quarters
Revenue YoY growth
-89.2%
Most recent quarter
EPS YoY growth
-16.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-0.2%
2025-08-07
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $-1.01 | +4.7% | $113.76 | $113.79 | +0.0% |
| 2025-11-05 | $-0.99 | -3.1% | $88.18 | $88.20 | +0.0% |
| 2025-08-07 | $-0.94 | +7.8% | $70.67 | $70.50 | -0.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.06 | $-1.01 | +4.7% | $1.65M | -89.2% |
| 2025-09-30 | $-0.96 | $-0.99 | -3.1% | $4.95M | -81.0% |
| 2025-06-30 | $-1.02 | $-0.94 | +7.8% | $7.55M | -72.4% |
| 2025-03-31 | $-0.76 | $-1.13 | -48.7% | $8.13M | -79.3% |
| 2024-12-31 | $-0.56 | $-0.87 | -56.3% | $15.27M | -75.8% |
| 2024-09-30 | $-0.34 | $-0.48 | -41.2% | $26.03M | +74.0% |
| 2024-06-30 | $-0.52 | $-0.51 | +1.9% | $27.38M | +91.5% |
| 2024-03-31 | $-0.51 | $-0.14 | +72.5% | $39.26M | +119.2% |
| 2023-12-31 | $-0.61 | $0.42 | +168.9% | $63.15M | — |
| 2023-09-30 | $-0.54 | $-0.81 | -50.0% | $14.96M | — |
| 2023-06-30 | $-0.31 | $-0.50 | -61.3% | $14.30M | — |
| 2023-03-31 | $1.82 | $-0.58 | -131.9% | $17.91M | — |
Frequently asked questions
Has Arcellx Inc beaten earnings estimates?
Arcellx Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -9.8% over the last 4 quarters.
How does ACLX stock react to earnings?
ACLX stock has moved an average of -0.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Arcellx Inc's revenue growth rate?
Arcellx Inc reported year-over-year revenue growth of -89.2% in its most recent quarter, with EPS growing -16.1% year-over-year.